3883 CDP-alcohol phosphotransferase helical bundle domain
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Hydrocarbons | 5 | 0.0 | 121× | not tested | |
| Lipids and lipid-like molecules | 4 | 0.7 | 6.07× | not tested | |
| Organic oxygen compounds | 2 | 1.2 | 1.70× | not tested | |
| Homogeneous metal compounds | 4 | 2.9 | 1.38× | not tested | |
| Nucleosides, nucleotides, and analogues | 2 | 1.6 | 1.22× | not tested | |
| Organic acids and derivatives | 1 | 0.9 | 1.09× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03831 | MPG | [(Z)-octadec-9-enyl] (2R)-2,3-bis(oxidanyl)propanoate | 6 |
| DB09459 | TLA | L-tartaric acid | 4 |
| DB03403 | C5P | Cytidine-5'-Monophosphate | 3 |
| DB02484 | C2G | Cytidine 5'-diphosphoglycerol | 2 |
| DB03542 | LIP | L-Myo-Inositol-1-Phosphate | 2 |
| DB04555 | CDP | Cytidine-5'-Diphosphate | 2 |
| DB02515 | G3P | sn-glycerol 3-phosphate | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| OLC | (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate | 10 |
| 8K6 | Octadecane | 9 |
| MGmetal | MAGNESIUM ION | 8 |
| 58A | 5'-O-[(R)-{[(S)-{(2R)-2,3-bis[(9E)-octadec-9-enoyloxy]propoxy}(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]cytidine | 6 |
| CAmetal | CALCIUM ION | 6 |
| MPG | [(Z)-octadec-9-enyl] (2R)-2,3-bis(oxidanyl)propanoate | 6 |
| NAmetal | SODIUM ION | 4 |
| TLA | L(+)-TARTARIC ACID | 4 |
| ZNmetal | ZINC ION | 4 |
| LFA | EICOSANE | 3 |
| C2G | [CYTIDINE-5'-PHOSPHATE] GLYCERYLPHOSPHORIC ACID ESTER | 2 |
| C5P | CYTIDINE-5'-MONOPHOSPHATE | 2 |
| CDP | CYTIDINE-5'-DIPHOSPHATE | 2 |
| FQT | [(2~{S})-3-[[[(2~{R},3~{S},4~{R},5~{R})-5-(6-azanyl-2-oxidanylidene-1,4-dihydropyrimidin-3-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxy-2-hexanoyloxy-propyl] hexanoate | 2 |
| LIP | L-MYO-INOSITOL-1-PHOSPHATE | 2 |
| MNmetal | MANGANESE (II) ION | 2 |
| OLB | (2S)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate | 2 |
| PO9 | [(2R)-2-hexadecanoyloxy-3-[oxidanyl-[(2S)-2-oxidanyl-3-phosphonooxy-propoxy]phosphoryl]oxy-propyl] (Z)-octadec-9-enoate | 2 |
| TCE | 3,3',3''-phosphanetriyltripropanoic acid | 2 |
| UPL | UNKNOWN BRANCHED FRAGMENT OF PHOSPHOLIPID | 2 |